U S Physical Therapy INC /NV Form 4 insider transactions

Director Bernard A. Harris Jr. acquired 1,424 shares of U.S. Physical Therapy Inc. as part of the company's Amended and Restated 2003 Stock Incentive Plan.

Director Kathleen A. Gilmartin reports acquisition of 1,424 shares of restricted stock in U.S. Physical Therapy Inc.

Clayton Trier, a director at U.S. Physical Therapy, acquired 1,424 shares of common stock as part of the company's Amended and Restated 2003 Stock Incentive Plan.

Carey Hendrickson, CFO of U.S. Physical Therapy, reported a gift of shares, resulting in a slightly reduced beneficial ownership.

Director Nancy Ham reports acquisition of 1,424 shares of restricted stock in U.S. Physical Therapy Inc.

Richard Binstein, EVP, General Counsel & Secretary of U.S. Physical Therapy, sold 2,111 shares of common stock at an average price of $106.34 on May 16, 2024.

Director Edward Kuntz of U.S. Physical Therapy Inc. reports selling 2,500 shares of common stock at an average price of $107.57 on May 15, 2024.

Eric Joseph Williams, Co-Chief Operations Officer of U.S. Physical Therapy, sold 2,500 shares of common stock at a weighted average price of $104.22 on May 10, 2024.

Graham D. Reeve, COO of U.S. Physical Therapy, Inc., sold 1,724 shares of common stock at a weighted average price of $105.46 on May 10, 2024.

Carey Hendrickson, CFO of U.S. Physical Therapy, reported selling shares of common stock on March 13, 2024.

Richard Binstein, EVP, General Counsel & Secretary of U.S. Physical Therapy Inc, sold 2,000 shares of common stock at a weighted average price of $106.55 on March 13, 2024.

Director Clayton Trier reported selling 400 shares of U.S. Physical Therapy Inc. at $107 per share on March 13, 2024.

Director Nancy Ham of U.S. Physical Therapy Inc. reports selling 500 shares of common stock at $107.89 per share on March 13, 2024.

Graham Reeve, COO of U.S. Physical Therapy, sold 2,629 shares of common stock at a weighted average price of $104.39 on March 4, 2024.

Eric Joseph Williams, Co-Chief Operations Officer of U.S. Physical Therapy, reports the sale of 1,500 shares of common stock on March 4, 2024.

Director Edward Kuntz of U.S. Physical Therapy Inc. reports selling 2,500 shares of common stock at an average price of $104.26 on March 4, 2024.

Christopher Reading, CEO of U.S. Physical Therapy, acquired 16,200 shares of common stock on February 26, 2024, as part of a restricted stock grant.

Graham D. Reeve, COO of U.S. Physical Therapy, received 8,100 shares of restricted stock on February 26, 2024, under the company's stock incentive plan.

Eric Williams, Co-Chief Operations Officer of U.S. Physical Therapy Inc., reports the acquisition of 8,100 shares of restricted stock granted under the company's stock incentive plan.

Richard Binstein, EVP, General Counsel & Secretary of U.S. Physical Therapy, acquired 8,100 shares of restricted stock on February 26, 2024, under the company's stock incentive plan.

Carey Hendrickson, CFO of U.S. Physical Therapy, received 8,100 shares of restricted stock on February 26, 2024, according to a Form 4 filing.